National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov
In English | En español
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Dictionary of Cancer Terms
In English   En español
Page Options
Print This Page
More NCI Dictionaries
NCI Drug Dictionary

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
In English   En español

yttrium Y 90 DOTA monoclonal antibody HuPAM4 (IH-tree-um ... MAH-noh-KLOH-nul AN-tee-BAH-dee...)

 A substance being studied in the treatment of advanced pancreatic cancer. HuPAM4 is a monoclonal antibody that can locate and bind to pancreatic cancer cells. It is linked to a radioactive substance called yttrium Y90, which may help kill cancer cells. Yttrium Y 90 DOTA monoclonal antibody HuPAM4 is a type of radioimmunoconjugate.



Previous Definitions:yoga, yohimbe, yttrium, yttrium Y 90, yttrium Y 90 DOTA anti-CEA monoclonal antibody M5A
Next Definitions:yttrium Y 90 DOTA-biotin, yttrium Y 90 DOTA-tyr3-octreotide, yttrium Y 90 edotreotide, yttrium Y 90 ibritumomab tiuxetan, yttrium Y 90 SMT 487

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov